AbbVie
The Associate Director, Immunology Payer Strategy leads the development and execution of the SKYRIZI payer strategy and customer narrative for psoriasis and psoriatic arthritis, translating insights and evidence into actionable market access plans. This role partners cross‑functionally to integrate payer considerations into brand strategy, evidence planning, and commercial execution.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
9% below the average for this role
VP of Access Strategy & Payer Engagement
Ocular Therapeutix
Director, HEOR Strategy, Global Immunology Pipeline
AbbVie
Director, HEOR Strategy, Global Immunology Pipeline
AbbVie
Director, Global Health Economics and Outcomes (GHEOR) - Immunology
Bristol Myers Squibb
Global Payer Evidence Lead Obesity
Novo Nordisk A/S
Head of Global RWE and HEOR Strategy - Immunology (BOS)
City of Winnipeg